EMA Medicine safety communications
Crysvita: adverse event
Published by European Medicines Agency: · Ref. EMAVR0000261369
Summary
Adverse event
Medicine
Crysvita
- Category
- Medicine safety communications
- Product type
- Human medicine
- Active substance(s): burosumab
- Therapeutic area: Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia
- ATC code: M05BX05
Measures and alternatives
- Regulatory outcome: Variation
Source: EMA — medicine safety communications — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗